Be cautious when a seller offers prescription medicines without an appropriate clinical assessment or prescription. Check the dispensing pharmacy, traceable premises and official register details independently; an attractive website can copy logos and names.
The MHRA warns against unregulated GLP-1 sellers, including social-media supply routes. Follow official safety information rather than assuming that a public price listing guarantees stock, authenticity or clinical suitability.
If you cannot verify the pharmacy or the details disagree, stop and ask a registered pharmacist for guidance. Report suspected medicine problems through the relevant official channels, including the MHRA Yellow Card service for suspected side effects.
